Stay ahead of developments in federal and state health care law, regulation and transactions with timely, expert news and analysis.
Oct. 5 — The White House's National Science and Technology Council Oct. 5 asked for input to update the federal framework for biotechnology regulation in order to clarify the federal agencies' roles.
In its request for information, set to be published in a Federal Register notice on Oct. 6, the NSTC indicated that responses must be received by Nov. 13.
The RFI responds to a July 2 memorandum from the Executive Office of the President (EOP) directing the primary agencies that regulate the products of biotechnology—the Food and Drug Administration, Environmental Protection Agency and Department of Agriculture—to update the Coordinated Framework for the Regulation of Biotechnology (CF) (51 Fed. Reg. 23,302, 6/26/86) and develop a long-term strategy to ensure that the federal biotechnology regulatory system is prepared for the future landscape of biotechnology. A commissioned expert regulatory analysis will help to develop the strategy.
The memorandum’s objectives are to ensure public confidence in the regulatory system and prevent unnecessary barriers to future innovation and competitiveness by improving the transparency, coordination, predictability and efficiency of the regulation of biotechnology products while continuing to protect health and the environment, the notice said.
The EOP memorandum said the CF update should clarify the current roles and responsibilities of the agencies that regulate the products of biotechnology through four objectives:
The term “biotechnology products” refers to products developed through genetic engineering or the targeted or in vitro manipulation of genetic information of organisms, including plants, animals and microbes.
Submit responses by Nov. 13, electronically to http://www.regulations.gov or by mail to the National Science and Technology Council, Emerging Technologies Interagency Policy Coordination Committee, Office of Science and Technology Policy, 1650 Pennsylvania Ave. N.W., Washington, D.C. 20504. All comments should reference Docket No. FDA-2015-N-3403.
Responses must be unclassified and shouldn't contain any proprietary, confidential or personally identifying information, such as home address or Social Security number. All information received will be publicly viewable at http://www.regulations.gov.
For further information, contact the National Science and Technology Council: Emerging Technologies Interagency Policy Coordination Committee, Office of Science and Technology Policy, Executive Office of the President, Eisenhower Executive Office Building, 1650 Pennsylvania Ave. N.W., Washington, D.C. 20504, (202) 456-4444.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)